Department of Pulmonology, Kameda Medical Center, Japan.
Department of Haematology, Kameda Medical Center, Japan.
Intern Med. 2022;61(5):623-632. doi: 10.2169/internalmedicine.6364-20. Epub 2022 Mar 1.
Objective Acute pulmonary lesions (APLs), defined as an acute infiltrate or nodular lung field, are a major complication in patients with haematological diseases. Recently, endobronchial ultrasonography with a guide-sheath (EBUS-GS) was established as a useful technique for diagnosing pulmonary lesions. This study aimed to evaluate the efficacy and safety of EBUS-GS for managing APLs in patients with haematological diseases. Methods Our single-centre, retrospective, observational, single-arm, descriptive study enrolled 22 consecutive adult (>20-year-old) patients with haematological diseases and concomitant APL who underwent EBUS-GS between January 2011 and June 2016 at Kameda Medical Center, Chiba, Japan. The primary endpoint was the contribution of EBUS-GS to clinical decision-making. Secondary endpoints were an adequate tissue collection rate, diagnostic yield, complication rate, and 30-day mortality. Results The median patient age was 70 years old, and 63.6% were men. Acute myeloid leukaemia was the most frequent underlying disease, accounting for 54.5% of patients. The contribution of EBUS-GS to clinical decision-making was recognised in 11 (50.0%) patients. Adequate tissue collection was achieved in 21 (95.5%) patients. The aetiology of the APL was identified in 9 (40.9%) patients. No complications, including severe haemorrhaging and pneumothorax, were observed in any patients, and the 30-day mortality rate was 0%. Conclusion EBUS-GS may be a suitable diagnostic option for APL in patients with haematological diseases. Further larger-scale and randomised controlled trials are needed to confirm our results.
急性肺部病变(APL)是指肺部急性浸润或结节,是血液病患者的主要并发症。近年来,支气管内超声引导下针吸活检术(EBUS-GS)已成为诊断肺部病变的一种有用技术。本研究旨在评估 EBUS-GS 治疗血液病患者 APL 的疗效和安全性。
本研究为单中心、回顾性、观察性、单臂、描述性研究,纳入了 2011 年 1 月至 2016 年 6 月在日本千叶县镰仓医疗中心接受 EBUS-GS 检查的 22 例合并 APL 的血液病成年(>20 岁)患者。主要终点为 EBUS-GS 对临床决策的贡献。次要终点为组织采集充分率、诊断率、并发症发生率和 30 天死亡率。
患者的中位年龄为 70 岁,63.6%为男性。急性髓系白血病是最常见的基础疾病,占 54.5%的患者。EBUS-GS 对 11 例(50.0%)患者的临床决策有帮助。21 例(95.5%)患者获得了充分的组织采集。9 例(40.9%)患者明确了 APL 的病因。无任何患者发生并发症,包括严重出血和气胸,30 天死亡率为 0%。
EBUS-GS 可能是血液病患者 APL 的一种合适的诊断选择。需要进一步进行更大规模和随机对照试验来证实我们的结果。